atopie

Atopie, or atopy, is a genetic predisposition to develop IgE-mediated allergic responses to environmental proteins. It is not a disease by itself, but a risk factor that increases the likelihood of allergic conditions such as atopic dermatitis (eczema), allergic rhinitis (hay fever), and asthma. Atopie commonly begins in childhood and can persist into adulthood.

Genetic and environmental factors interact in atopie. Individuals with atopy tend to produce allergen-specific IgE antibodies and may display a Th2-skewed immune response. Variants involved in skin barrier function, such as filaggrin gene mutations, can promote sensitization through the skin. Family history of allergic disease is common in those with atopy.

Clinical expression varies with age. Eczema can appear in infancy, while allergic rhinitis and asthma may develop later. Diagnosis relies on clinical history and examination, supported by objective tests such as skin prick testing or serum-specific IgE testing. Total IgE levels can be elevated but are not diagnostic.

Management focuses on avoidance of known triggers where feasible, symptom control, and, in selected cases, immunotherapy. Treatments include moisturizers and topical therapies for eczema; antihistamines and intranasal steroids for rhinitis; inhaled corticosteroids and bronchodilators for asthma. Allergen-specific immunotherapy and certain biologic therapies may be appropriate for some patients under specialist care.

Prognosis varies; many individuals with atopy experience improvement or resolution of symptoms over time, while others continue to have allergic diseases into adulthood. The prevalence of atopy varies across populations and is influenced by genetic background and environmental exposures.